Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 39,391 |
|
|||||
| News | - | ||||||
| Day High | 5.25 | Low High |
|||||
| Day Low | 5.1299 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Editas Medicine Inc | EDIT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.05 | -0.96% | 5.17 | 09:37:39 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.25 | 5.1299 | 5.25 | 5.22 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 289 | 39,391 | $ 5.21 | $ 205,040 | - | 5.11 - 11.91 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:37:39 | 2,000 | $ 5.17 | USD |
Editas Medicine Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 427.07M | 81.81M | - | 78.12M | -153.22M | -1.87 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Editas Medicine News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical EDIT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.52 | 5.92 | 5.11 | 5.43 | 1,805,591 | -0.35 | -6.34% |
| 1 Month | 7.41 | 7.41 | 5.11 | 6.18 | 1,700,795 | -2.24 | -30.23% |
| 3 Months | 7.09 | 11.58 | 5.11 | 7.85 | 1,948,882 | -1.92 | -27.08% |
| 6 Months | 6.65 | 11.69 | 5.11 | 8.65 | 1,896,532 | -1.48 | -22.26% |
| 1 Year | 7.78 | 11.91 | 5.11 | 8.65 | 1,839,034 | -2.61 | -33.55% |
| 3 Years | 36.98 | 73.025 | 5.11 | 18.29 | 1,752,738 | -31.81 | -86.02% |
| 5 Years | 27.25 | 99.95 | 5.11 | 25.57 | 1,530,065 | -22.08 | -81.03% |
Editas Medicine Description
| Editas Medicine Inc is a gene-editing company. It is engaged in treating patients with genetically defined diseases by correcting disease-causing genes. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company's only operating segment is developing and commercializing genome editing technology. |
